ReviewWorld journal of virology2021

Are nucleotide inhibitors, already used for treating hepatitis C virus infection, a potential option for the treatment of COVID-19 compared with standard of care? A literature review.

Anna Maria SperaPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.